These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Topical nonsteroidal anti-inflammatory drugs in uncomplicated cataract surgery: Effect of sodium naproxen. Russo P; Papa V; Russo S; Di Bella A; Pabst G; Milazzo G; Balestrazzi A; Caporossi A; The Naproxen Study Group F Eur J Ophthalmol; 2005 Sep - Oct 2005; 15(5):598-606. PubMed ID: 28221461 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness and tolerance of piroxicam 0.5% and diclofenac sodium 0.1% in controlling inflammation after cataract surgery. Scuderi B; Driussi GB; Chizzolini M; Salvetat ML; Beltrame G Eur J Ophthalmol; 2003 Jul; 13(6):536-40. PubMed ID: 12948311 [TBL] [Abstract][Full Text] [Related]
4. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery. Flach AJ; Dolan BJ; Donahue ME; Faktorovich EG; Gonzalez GA Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery. Bodaghi B; Weber ME; Arnoux YV; Jaulerry SD; Le Hoang P; Colin J Eur J Ophthalmol; 2005; 15(6):702-11. PubMed ID: 16329054 [TBL] [Abstract][Full Text] [Related]
6. Naproxen ophthalmic solution to manage inflammation after phacoemulsification. Papa V; Milazzo G; Santocono M; Servolle V; Sourdille P; Santiago PY; Darondeau J; Cassoux N; LeHoang P J Cataract Refract Surg; 2002 Feb; 28(2):321-7. PubMed ID: 11821217 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of a novel meloxicam ophthalmic formulation with a reference diclofenac solution in cataract surgery. Baiza-Duran LM; Quintana-Hau J; Tornero-Montaño R; Ortiz MI; Castañeda-Hernández G; Alanis-Villarreal L; Avalos-Urzua G; Bustos-Zermeño R; Domene-Hinojosa JL; Gómez-Bastar P; Ibañez-Hernandez MA; Morales-Gómez ME; Velasco-Gallegos G; Villar-Kuri J Int J Clin Pharmacol Ther; 2009 Feb; 47(2):89-95. PubMed ID: 19203564 [TBL] [Abstract][Full Text] [Related]
8. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells. el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003 [TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery. Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the Effect of Diclofenac 0.1% and Nepafenac 0.1% on Aqueous Flare in Patients Undergoing Cataract Surgery: A Prospective Randomized Study. Cagini C; Pellegrino A; Cerquaglia A; Iaccheri B; Lupidi M; Fiore T Curr Eye Res; 2020 Sep; 45(9):1089-1093. PubMed ID: 32004437 [TBL] [Abstract][Full Text] [Related]